O-0008ABITUZUMAB COMBINED WITH CETUXIMAB PLUS IRINOTECAN VERSUS CETUXIMAB PLUS IRINOTECAN ALONE, AS SECOND-LINE TREATMENT FOR PATIENTS WITH KRAS WILD-TYPE METASTATIC COLORECTAL CANCER: THE POSEIDON PHASE I/RANDOMIZED PHASE II TRIAL
2014
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI